Literature DB >> 12203396

Multiple angiotensin receptor subtypes in normal and tumor astrocytes in vitro.

David J Fogarty1, M Victoria Sánchez-Gómez, Carlos Matute.   

Abstract

A role for neuropeptide receptors in glial tumorigenesis has recently been proposed. Although angiotensin receptors are known to mediate proliferative effects in many cell types, including brain astrocytes, the possible participation of these receptors in glial tumorigenesis remains unknown. In the present study, we have examined the expression of the molecularly defined angiotensin receptor subtypes AT(1a), AT(1b), and AT(2) in normal perinatal rat astrocytes and in a panel of tumor adult astrocytoma cells, using the reverse transcriptase-polymerase chain reaction (RT-PCR). Subsequently, we compared the mitogenic effect of the angiotensins A(1-8), A(2-8), A(3-8) and the heptapeptide "metabolite" A(1-7), on both normal and tumor astrocytes, measured in terms of the incorporation of tritiated thymidine. Our results indicate that AT(1a), AT(1b), and AT(2) angiotensin receptor mRNA is commonly expressed by many of these cells. Of notable exception is the astrocytoma U373 which was not found to express AT(1) or AT(2) mRNA. Chronic (24-h) incubation of cells with A(1-8) and A(1-7) lead to the induction of mitogenesis, even in the AT(1) and AT(2) mRNA negative astrocytoma cell line U373. Moreover, pharmacological analysis indicated that the observed mitogenic effects are not mediated by the AT(1) or AT(2) type receptors, but rather by a novel, specific A((1-7)) angiotensin receptor, since mitogenesis was shown to be partially blocked by the A(1-7) analogue D-Ala(7)A(1-7) and by the protease inhibitor orthophenanthroline (100 microM). Using Fura-2 spectrophotometry, we found that activation of this receptor does not alter intracellular calcium levels; however, preincubation with the protein kinase kinase inhibitor U0126 (10 microM) was found to inhibit these mitogenic effects partially. Overall, these results which demonstrate that normal and tumor astrocytes express a greater variety of angiotensin receptor subtypes than previously thought, support the idea that A(1-7) and its receptor signaling system may play an important role in shaping the astrocyte population during development. Moreover, the untimely expression of this A((1-7)) receptor may represent an important etiological component in the development of brain astrocytomas. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203396     DOI: 10.1002/glia.10117

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  14 in total

1.  Expression of astrocytic type 2 angiotensin receptor in central nervous system inflammation correlates with blood-brain barrier breakdown.

Authors:  Laila Füchtbauer; Henrik Toft-Hansen; Reza Khorooshi; Trevor Owens
Journal:  J Mol Neurosci       Date:  2010-04-23       Impact factor: 3.444

2.  Impact of Angiotensin-II receptor blockers on vasogenic edema in glioblastoma patients.

Authors:  Antoine Kourilsky; Guillaume Bertrand; Renata Ursu; Jennifer Doridam; Ciprian Barlog; Thierry Faillot; Emmanuel Mandonnet; Catherine Belin; Christine Levy; Antoine F Carpentier
Journal:  J Neurol       Date:  2016-01-11       Impact factor: 4.849

3.  Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?

Authors:  Caroline Happold; Thierry Gorlia; L Burt Nabors; Sara C Erridge; David A Reardon; Christine Hicking; Martin Picard; Roger Stupp; Michael Weller
Journal:  J Neurooncol       Date:  2018-02-08       Impact factor: 4.130

4.  Angiotensin receptor type 1 blockade in astroglia decreases hypoxia-induced cell damage and TNF alpha release.

Authors:  Lusine Danielyan; Ali Lourhmati; Stephan Verleysdonk; Daniela Kabisch; Barbara Proksch; Ulrike Thiess; Sumaira Umbreen; Boris Schmidt; Christoph H Gleiter
Journal:  Neurochem Res       Date:  2007-04-04       Impact factor: 3.996

5.  Adeno-Associated Virus Overexpression of Angiotensin-Converting Enzyme-2 Reverses Diabetic Retinopathy in Type 1 Diabetes in Mice.

Authors:  James M Dominguez; Ping Hu; Sergio Caballero; Leni Moldovan; Amrisha Verma; Gavin Y Oudit; Qiuhong Li; Maria B Grant
Journal:  Am J Pathol       Date:  2016-05-10       Impact factor: 4.307

6.  Activation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction.

Authors:  J Zheng; G Li; S Chen; J Bihl; J Buck; Y Zhu; H Xia; E Lazartigues; Y Chen; J E Olson
Journal:  Neuroscience       Date:  2014-05-09       Impact factor: 3.590

7.  The effect of angiotensin II and IV on ERK1/2 and CREB signalling in cultured rat astroglial cells.

Authors:  Adam Holownia; Jan J Braszko
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-19       Impact factor: 3.000

Review 8.  Renin angiotensin system and its role in biomarkers and treatment in gliomas.

Authors:  Alexander Perdomo-Pantoja; Sonia Iliana Mejía-Pérez; Liliana Gómez-Flores-Ramos; Montserrat Lara-Velazquez; Cordelia Orillac; Juan Luis Gómez-Amador; Talia Wegman-Ostrosky
Journal:  J Neurooncol       Date:  2018-02-16       Impact factor: 4.130

9.  Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma.

Authors:  O Arrieta; P Guevara; E Escobar; R García-Navarrete; B Pineda; J Sotelo
Journal:  Br J Cancer       Date:  2005-04-11       Impact factor: 7.640

10.  Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis.

Authors:  O Arrieta; B Pineda-Olvera; P Guevara-Salazar; N Hernández-Pedro; D Morales-Espinosa; T L Cerón-Lizarraga; C H González-De la Rosa; D Rembao; B Segura-Pacheco; J Sotelo
Journal:  Br J Cancer       Date:  2008-07-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.